# Ardelyx, Inc. – FDA Inspection, Jul 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/ardelyx-inc/7a235bd5-1b51-4cfa-8fc7-3cb7d8ccc158
Source feed: FDA_Inspections

> FDA inspection 1210671 of Ardelyx, Inc., July 24, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210671
- Company Name: Ardelyx, Inc.
- Inspection Date: 2023-07-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1083980 - 2019-03-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/ardelyx-inc/ca34caa9-3440-4e27-a0d0-177a42cc469e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
